Roche

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer
Pharmaceutical Business Review
Fri, 12/13/19 - 12:20 pm
Roche
Perjeta
Herceptin
HER2+ breast cancer
SABCS
breast cancer
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Thu, 12/12/19 - 11:12 am
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer
SABCS: Roche's Perjeta builds case as add-on to Herceptin with new analysis
Fierce Pharma
Wed, 12/11/19 - 10:35 am
Roche
breast cancer
Herceptin
Perjeta
biosimilars
SABCS
Roche extends tender offer for Spark Therapeutics, again
Marketwatch
Mon, 12/9/19 - 11:42 pm
Roche
Spark Therapeutics
M&A
Disruptor of the Year: The Federal Trade Commission
Biopharma Dive
Mon, 12/9/19 - 11:16 pm
FTC
M&A
Roche
Spark Therapeutics
ASH: Roche bispecific delivers for hard-to-treat lymphoma patients failed by CAR-Ts
Fierce Biotech
Mon, 12/9/19 - 09:48 am
Roche
ASH2019
non-Hodgkin lymphoma
mosunetuzumab
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
Sun, 12/8/19 - 10:12 pm
AbbVie
Roche
CLL
ASH2019
Venclexta
FDA approves Roche’s MRSA test, allowing for faster screening
Pharmaforum
Fri, 12/6/19 - 09:55 am
FDA
Roche
MRSA
diagnostics
cobas vivoDx
Novartis pulls rival to Roche’s risdiplam in SMA, says market limited
Pharmaforum
Fri, 12/6/19 - 09:51 am
Novartis
Roche
SMA
risdiplam
branaplam
Roche gets FDA nod for Tecentriq plus chemotherapy to treat metastatic NSCLC
Pharmaceutical Business Review
Wed, 12/4/19 - 10:20 am
Roche
Tecentriq
metastatic non-squamous non-small cell lung cancer
FDA
Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Fierce Pharma
Tue, 12/3/19 - 10:02 am
Roche
Mylan
Herceptin
biosimilar
cancer
oncology
Ogivri
Roche trumpets data for Soliris rival in NMOSD after US, EU filings
Pharmaforum
Mon, 12/2/19 - 10:34 am
Roche
satralizumab
neuromyelitis optica spectrum disorder
NMOSD
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Drugs firms make massive discounts to get reimbursement in China
Pharmaforum
Fri, 11/29/19 - 02:33 pm
Roche
Novartis
China
reimbursement
Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says
Fierce Pharma
Wed, 11/27/19 - 12:34 pm
Roche
Genentech
Xofluza
pediatrics
Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'
Endpoints
Tue, 11/26/19 - 11:39 pm
Roche
Xofluza
Japan
Shionogi
Flu
influenza
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Roche
PTC Therapeutics
SMA
risdiplam
Biogen
Spinraza
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Mon, 11/25/19 - 09:47 am
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Which asthma biologic do docs prefer? It's not that simple: analyst
Fierce Pharma
Sat, 11/23/19 - 03:47 pm
asthma
Roche
Novartis
Xolair
Sanofi
Regeneron
Dupixent
physicians
Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time
Endpoints
Fri, 11/22/19 - 10:37 am
Roche
M&A
Spark Therapeutics

Pages